abstract |
Compounds of formula (I) (wherein R 1 , HET-1 and HET-2 are those described in the specification) and their salts are activators of glucokinase (GLK), which For example, it is useful for the treatment of type 2 diabetes. Also described are methods for preparing compounds of formula (I). |